 |
| Donald McDonnell, PhD |
CANCER DIGEST – Oct. 15, 2014 – Loading up prostate cancer tumors with copper and then treating them with a drug that acts selectively on cells crammed with the mineral may provide a new treatment approach for the prostate cancer, Duke Medicine researchers say.
In a study published in today’s journal Cancer Research the new approach uses two drugs already FDA-approved for other uses, and could soon be tested in human clinical trials of men with late stage prostate cancer.
